Environmental exposure to
Acanthamoeba spp. is common, as viable
Acanthamoeba trophozoites have been isolated from nasopharyngeal and oral specimens collected from asymptomatic individuals.
2 Moreover, peripheral blood lymphocytes from 50% of healthy individuals demonstrated T-cell proliferative responses to
Acanthamoeba antigens, suggesting that environmental exposure to this protozoan stimulates the adaptive immune apparatus.
8 At least one component of the adaptive immune apparatus, anti-
Acanthamoeba secretory IgA antibody, protects against disease by preventing trophozoite adhesion to the corneal epithelium by augmenting neutrophil-mediated lysis of trophozoites, and by inhibiting MIP-133–mediated lysis of the corneal epithelium and stroma.
9 Mucosal IgA antibodies to
Acanthamoeba antigens and MIP-133 are the only effective component of the adaptive immune response that seem to be capable of controlling
Acanthamoeba keratitis and are only effective if induced before corneal infections are initiated in experimental animals.
10 11 12 13 14 15 16 17 18 The adaptive immune response also appears to be ineffective in controlling
Acanthamoeba keratitis in humans, as acute infections occur in the presence of IgG serum antibodies specific for
Acanthamoeba antigens in patients with
Acanthamoeba keratitis, including those with recrudescent infections.
10 However, the adaptive recrudescence can occur in hosts not possessing anti-
Acanthamoeba IgA antibodies, indicating that the adaptive immune apparatus is not effective at preventing reinfection.